Detalhe da pesquisa
1.
Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.
Cell Mol Neurobiol
; 38(5): 1099-1106, 2018 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-29623478
2.
A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma.
Oncologist
; 22(8): 888-e84, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28679644
3.
Phase II Clinical Trial of Ixabepilone in Metastatic Cervical Carcinoma.
Oncologist
; 20(7): 725-6, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26040622
4.
Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer.
Clin Cancer Res
; 14(9): 2710-6, 2008 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18451236
5.
Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.
Clin Cancer Res
; 22(20): 4989-5000, 2016 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27742785
6.
Brain metastasis in patients with adrenocortical carcinoma: a clinical series.
J Clin Endocrinol Metab
; 100(2): 331-6, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25412413
7.
The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.
J Clin Endocrinol Metab
; 99(4): 1291-7, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24423320